Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Inhibrx, Inc. (INBX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/29/2021 |
3
| Vuori Kristiina MD (Director) has filed a Form 3 on Inhibrx, Inc. |
| 08/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/18/2020 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| Lappe Mark (CEO) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| Deck Kelly (CFO) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| Deveraux Quinn L. (10% Owner) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| Wagner Klaus W. (Chief Medical Officer) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| MANHARD KIMBERLY (Director) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| FORSYTH DOUGLAS (Director) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| Kayyem Jon Faiz (10% Owner) has filed a Form 3 on Inhibrx, Inc. |
| 08/18/2020 |
3
| Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 3 on Inhibrx, Inc. |
|
|